Dawnrays Pharmaceutical (Holdings) Limited
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
10/10
|
4.29 | 36.59 | -88.28% | 6.13 | -29.99% |
| P/S |
|
1.21 | 7.13 | -82.98% |
|
|
| P/BV |
|
0.4889 | 3.66 | -86.63% |
|
|
| P/FCF |
|
14.24 | -11.82 | -220.53% |
|
|
| Ev/Ebitda |
|
1.45 | 2.91 | -50.14% |
|
|
| Ev/S |
|
0.6363 | 16.44 | -96.13% |
|
|
| Ev/FCF |
|
5.8 | -7.89 | -173.49% |
|
|
| E/P |
|
0.1811 | 0.0325 | 457.88% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
10/10
|
43.89 | -9.7 | -552.42% | 38.94 | +12.71% |
| ROE |
|
11.86 | 4.42 | 168.44% |
|
|
| ROA |
|
8.94 | 2.95 | 203.06% |
|
|
| ROIC |
|
0 | 0 | 0% |
|
|
| ROS |
|
28.32 | -11.15 | -354.03% |
|
|
| ROCE |
|
0 | 0.1527 | -100% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
0.0166 | 0.7677 | -97.83% | 0.069 | -75.92% |
| Nеt Debt/Ebitda |
|
0 | 0.0174 | -100% |
|
|
| Debt/Ratio |
|
0.0023 | 0.1212 | -98.09% |
|
|
| Debt/Equity |
|
0.0065 | 0.8042 | -99.2% |
|
|
| Debt/Net Income |
|
0.0258 | 1.54 | -98.32% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
10/10
|
10 | 5.7 | 75.44% | 6.96 | +43.63% |
| Number of years of dividend growth |
|
3 | 1.13 | 166.67% | ||
| DSI |
|
0.8571 | 0.5838 | 46.82% |
|
|
| Average dividend growth |
|
-3.51 | 3.2 | -209.51% |
|
|
| Average percentage for 5 years |
|
6.96 | 4.95 | 40.59% |
|
|
| Average percentage for payments |
|
39.29 | 24.82 | 58.32% |
|
|
| Difference from average difference in sector |
|
4.3 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
4/10
|
21.17 | 1.85 | 1044.32% | ||
| Growth impulse Ebitda in 5 years |
|
18.18 | -44.43 | -140.92% | ||
| Growth impulse Net Income in 5 years |
|
27.63 | 58.07 | -52.42% | ||
| Growth impulse FCF in 5 years |
|
-29.04 | -7.48 | 288.24% | ||
| Growth impulse EPS in 5 years |
|
32.21 | -198.43 | -116.23% |
IP Score
6.79/10
